Understanding Modified Release Technologies
PAT-based analysis methodologies help see, quality and quantify subtle changes in dosage forms
In biopharma, budgets are returning and manufacturers are emphasizing innovation, productivity, and cost control.
Looking for Supply Chain Answers in 2011
Interest in protecting the drug supply chain is becoming top of mind for drug manufacturers, technology providers, and governments as they begin to understand the current and elevated risks to patient safety.
Biotech Production: Planning, Scheduling and Throughput Analysis with a Combined Theory of Constraints, Lean and Simulation Approach
A major biotech company's only final stage bio-manufacturing facility in the world was struggling to meet rapidly increasing customer demand. Unanticipated production delays and frequent starvations at critical parts of the operation were causing not only late and missed deliveries, but also the expiration of product batches at a cost of approximately $1 million per batch.